Market Closed -
Nyse
16:00:00 2024-05-22 EDT
5-day change
1st Jan Change
7.16
USD
+7.99%
+7.03%
-32.07%
InfuSystem Holdings Inc. Promotes Carrie Lachance to Chief Operating Officer
October 02, 2019 at 06:39 am
On October 2, 2019, InfuSystem Holdings Inc. announced that Carrie Lachance has been promoted to Chief Operating Officer, effective October 1, 2019.
InfuSystem Approves $20 Million Share Buyback Plan -- Shares Rise After Hours
05-20
MT
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.
05-20
CI
InfuSystem Holdings, Inc. announces an Equity Buyback for $20 million worth of its shares.
05-20
CI
InfuSystem Holdings, Inc.'s Equity Buyback announced on May 20, 2024, has expired with 553,149 shares, representing 2.67% for $6.16 million.
05-19
CI
InfuSystem Holdings Inc. authorizes a Buyback Plan.
05-19
CI
InfuSystem Holdings, Inc. Approves Directorate Elections
05-17
CI
Transcript : InfuSystem Holdings, Inc. - Shareholder/Analyst Call
05-16
Transcript : InfuSystem Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09
InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2024
05-09
CI
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q1 Revenue $32M
05-09
MT
InfuSystem Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-09
CI
Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc
04-10
CI
Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024
03-14
Infusystem Announces Operational And Financial Results For Q4 And FY 2023
03-14
RE
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q4 Revenue $31.8M
03-14
MT
InfuSystem Holdings, Inc. Provides Earnings Guidance for the Full Year 2024
03-14
CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
03-14
CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
03-14
CI
InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board
03-08
CI
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.
11-09
CI
Transcript : InfuSystem Holdings, Inc., Q3 2023 Earnings Call, Nov 07, 2023
11-07
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q3 Revenue $31.9M
11-07
MT
InfuSystem Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-07
CI
InfuSystem Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023
11-07
CI
InfuSystem Holdings, Inc. Raises Earnings Guidance for the Full Year 2023
11-07
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segmentâs core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
More about the company
Last Close Price
7.16
USD
Average target price
14.83
USD
Spread / Average Target
+107.17%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
INFUSYSTEM HOLDINGS, INC. 
